Amryt Pharma plc AMYT
14.70 +14.70
Day range unavailable
52-week range unavailable
- Analysts
- Buy
- Price target
- 18.67 (+27.0%)
- Earnings date
- May 3, 2023
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Analyst view
Consensus: buy
Buy
Price target (mean) 18.67 +27.0% upside
Now 14.70
- Target (low)
- 14.50
- Target (mean)
- 18.67
- Target (high)
- 27.00
Ratings (-1m) 7 1 buy · 6 hold · 0 sell
- Strong buy1
- Buy0
- Hold6
- Sell0
- Strong sell0
Next earnings
May 3, 2023
Expected May 3, 2023. Consensus EPS estimate -0.03.
Financials — quick view
AMYT Revenue — quarterly 61.13M
AMYT Net income — quarterly -20.80M
AMYT EPS — quarterly -0.30
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 3, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Apr 5, 2023 | Dec 1, 2022 | -0.04 | — | — | — |
| Nov 3, 2022 | Sep 1, 2022 | -0.04 | — | — | — |
| Aug 4, 2022 | Jun 1, 2022 | -0.04 | — | — | — |
| May 4, 2022 | Mar 1, 2022 | -0.05 | — | — | — |
| Mar 9, 2022 | Dec 1, 2021 | -0.14 | — | — | — |
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on AMYT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| EdgePoint Investment Group, Inc. | — | Decrease | Aug 5, 2021 | 2,277,964 |
| Highbridge Capital Management, LLC | — | Holding | Mar 22, 2020 | 640,826 |
| Stafford (Ray) | — | Bought | Nov 28, 2021 | 50,000 |
| Stonepine Capital, L.P. | — | Holding | Dec 7, 2020 | 1,880,402 |
| UBS O'Connor, L.L.C. | — | Increase | Oct 6, 2020 | 1,993,524 |